Independent · evidence-based · non-judgmentalDraft · pending medical review
Not yet medically reviewed — information on this site is in preparation and has not been verified by a medical reviewer.
Drug index / Stimulant / Amphetamine
Stimulant

Amphetamine

1-phenylpropan-2-amine

Amphetamine (e.g., Adderall) is a prescription stimulant for ADHD and narcolepsy; misuse strains the heart, can cause dependence and psychosis, and is dangerous combined with other drugs.

Overview

Amphetamine is a prescription stimulant, most familiar as the mixed amphetamine salts sold under the brand name Adderall, used to treat attention-deficit/hyperactivity disorder (ADHD), narcolepsy, and (in some formulations) binge-eating disorder. Taken as prescribed under medical supervision it can improve attention and reduce impulsivity and hyperactivity, but it is a controlled substance with a recognized potential for misuse, dependence, and addiction. Misuse — taking more than prescribed, using it without a prescription (for example to study or stay awake), or taking it by routes other than swallowing — raises the risks substantially. Regulators have strengthened warnings about the serious risks of prescription stimulants, including misuse, addiction, overdose, and death.

Source: NIDA; FDA; DEA

Chemistry & mechanism of action

Amphetamine increases the activity of the neurotransmitters dopamine and norepinephrine in the brain, boosting alertness, attention, and energy and, at higher doses, producing euphoria that can reinforce repeated use. The same stimulation activates the cardiovascular system, raising heart rate and blood pressure. In people with ADHD, carefully dosed stimulant medication can improve focus; at higher or misused doses the same mechanisms drive the drug's dangers — cardiovascular strain, agitation, and, with heavy use, disruption of normal dopamine signaling that can affect mood and behavior. With repeated misuse, tolerance and dependence can develop.

Source: NIDA; PubChem CID 3007

Effects

At therapeutic doses, amphetamine improves attention and wakefulness and can suppress appetite. Common effects, especially at higher or misused doses, include increased energy and alertness, euphoria, talkativeness, reduced appetite, insomnia, dry mouth, and a faster heartbeat. As the dose rises, effects can include anxiety, restlessness, irritability, raised blood pressure, and — at high doses or with heavy use — paranoia, hallucinations, and stimulant psychosis. Coming down can bring fatigue, low mood, and difficulty concentrating. Long-term misuse is associated with cardiovascular problems, weight loss, sleep disruption, and mental-health effects.

Source: NIDA; FDA

Risks & harms

The main acute danger is cardiovascular: amphetamine raises heart rate and blood pressure and can, particularly at high doses or in people with underlying heart conditions, contribute to dangerously high blood pressure, irregular heart rhythms, heart attack, stroke, seizures, or dangerously high body temperature. Unlike opioids, there is no reversal medication for a stimulant overdose — emergency care is the response, so chest pain, severe agitation, very high temperature, or seizures mean calling 911. Combining amphetamine with other stimulants (including cocaine or large amounts of caffeine) compounds cardiovascular strain, and combining it with opioids or other depressants is dangerous because the stimulant can mask sedation and lead to taking more of the depressant. Heavy or high-dose use can trigger stimulant psychosis. Misuse can lead to dependence, and any pill obtained outside a licensed pharmacy can be a counterfeit containing other substances, including fentanyl, so naloxone is worth having on hand. For poisoning guidance call Poison Control at 1-800-222-1222; for substance-use support the SAMHSA National Helpline is 1-800-662-4357.

Source: NIDA; FDA; SAMHSA

Images

Visual references coming soon.

If it’s too intense

If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.

  • Get to a calm, safe space with someone you trust who is sober and can stay with you.
  • Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
  • Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
  • Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
  • A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
  • Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.

With stimulants, overheating and a racing heart are the main concerns — get somewhere cool, stop any physical activity, and don't take more.

Call 911 (or Poison Control, 1-800-222-1222) right away for chest pain, a very high body temperature, a seizure, unconsciousness, or severe confusion. These are medical emergencies, not something to wait out.

Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.

Forensic dossier

Draft · every field is source-cited or marked “Unknown — pending review”

Identity

IUPAC name
1-phenylpropan-2-aminePubChem PUG-REST · retrieved 2026-06-18
InChIKey
KWTSXDURSIMDCE-UHFFFAOYSA-NPubChem PUG-REST · retrieved 2026-06-18
Synonyms / aliases
speed, Amfetamine, 1-phenylpropan-2-amine, dl-Amphetamine, 1-Phenyl-2-aminopropane, Desoxynorephedrine, Norephedrane, Elastonon, Fenopromin, Phenedrine, beta-AminopropylbenzenePubChem PUG-REST + seed aliases · retrieved 2026-06-18

Composition

Composition
N/A — single compound (see Identity)

Physical / pill characteristics

Dosage form
HUMAN PRESCRIPTION DRUGopenFDA drug label · retrieved 2026-06-18
Shape
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Color
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Imprint
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Score
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)

Scheduling & legal status

US schedule
Unknown — pending review
International
Unknown — pending review

Pill catalog

Rx/OTC variants · openFDA + DailyMed (public domain) · draft, pending review

This drug comes in 300different versions. Make sure you’re looking at the right one — use the search above to find your exact pill by imprint, color, or shape.

Showing 300 of 300 variants

M Amphet S
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
M Amphet Salts 10 mg
Color
BLUE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Sandoz Inc
Schedule
CII
NDC
0781-2335 · 2026-06-18
N31
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
N31
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
SUNRISE PHARMACEUTICAL, INC.
Schedule
CII
NDC
11534-192 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
71335-1249 · 2026-06-18
N29
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
N29
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
SUNRISE PHARMACEUTICAL, INC.
Schedule
CII
NDC
11534-190 · 2026-06-18
N30
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DE
Imprint
N30
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
SUNRISE PHARMACEUTICAL, INC.
Schedule
CII
NDC
11534-191 · 2026-06-18
E 111
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
E 111
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
Sandoz Inc
Schedule
CII
NDC
0185-0842 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTROAMPHETAMINE
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
71335-0171 · 2026-06-18
AMG 277
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE DL-ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; D
Imprint
AMG 277
Color
GREEN
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
ANI Pharmaceuticals, Inc.
Schedule
CII
NDC
43975-277 · 2026-06-18
30 mgM 895
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
30 mgM 8956
Color
orange
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-8956 · 2026-06-18
N32
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DE
Imprint
N32
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
SUNRISE PHARMACEUTICAL, INC.
Schedule
CII
NDC
11534-193 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Lannett Company, Inc.
Schedule
CII
NDC
0527-0794 · 2026-06-18
N33
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
N33
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
SUNRISE PHARMACEUTICAL, INC.
Schedule
CII
NDC
11534-194 · 2026-06-18
N34
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
N34
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
SUNRISE PHARMACEUTICAL, INC.
Schedule
CII
NDC
11534-195 · 2026-06-18
AMG 281
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE DL-ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; D
Imprint
AMG 281
Color
PINK
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
ANI Pharmaceuticals, Inc.
Schedule
CII
NDC
43975-281 · 2026-06-18
Lannett 07
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
Lannett 0793
Color
orange
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Golden State Medical Supply, Inc.
Schedule
CII
NDC
51407-560 · 2026-06-18
G10 113
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
G10 113
Color
white
Shape
OVAL
Form
TABLET
Labeler
Granules Pharmaceuticals Inc.
Schedule
CII
NDC
70010-113 · 2026-06-18
N35
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
N35
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
SUNRISE PHARMACEUTICAL, INC.
Schedule
CII
NDC
11534-196 · 2026-06-18
AMG 278
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE DL-ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEX
Imprint
AMG 278
Color
GREEN
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
ANI Pharmaceuticals, Inc.
Schedule
CII
NDC
43975-278 · 2026-06-18
LANNETT 07
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
LANNETT 0790
Color
white
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Golden State Medical Supply, Inc.
Schedule
CII
NDC
51407-557 · 2026-06-18
G5 111
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
G5 111
Color
white
Shape
OVAL
Form
TABLET
Labeler
Granules Pharmaceuticals Inc.
Schedule
CII
NDC
70010-111 · 2026-06-18
AMG 279
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE DL-ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; D
Imprint
AMG 279
Color
GREEN
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
ANI Pharmaceuticals, Inc.
Schedule
CII
NDC
43975-279 · 2026-06-18
Lannett 07
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
Lannett 0791
Color
blue
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Golden State Medical Supply, Inc.
Schedule
CII
NDC
51407-558 · 2026-06-18
G7 5 112
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DE
Imprint
G7 5 112
Color
white
Shape
ROUND
Form
TABLET
Labeler
Granules Pharmaceuticals Inc.
Schedule
CII
NDC
70010-112 · 2026-06-18
AMG 280
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE DL-ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROA
Imprint
AMG 280
Color
PINK
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
ANI Pharmaceuticals, Inc.
Schedule
CII
NDC
43975-280 · 2026-06-18
Lannett 07
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
Lannett 0792
Color
blue
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Golden State Medical Supply, Inc.
Schedule
CII
NDC
51407-559 · 2026-06-18
A1
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 3.1 mg/1
Imprint
A1
Color
orange
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Neos Therapeutics, LP
Schedule
CII
NDC
62542-005 · 2026-06-18
G30 117
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
G30 117
Color
white
Shape
OVAL
Form
TABLET
Labeler
Granules Pharmaceuticals Inc.
Schedule
CII
NDC
70010-117 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Lannett Company, Inc.
Schedule
CII
NDC
0527-0795 · 2026-06-18
AMG 282
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE DL-ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEX
Imprint
AMG 282
Color
PINK
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
ANI Pharmaceuticals, Inc.
Schedule
CII
NDC
43975-282 · 2026-06-18
Lannett 07
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
Lannett 0794
Color
orange
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Golden State Medical Supply, Inc.
Schedule
CII
NDC
51407-561 · 2026-06-18
G12 5 114
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DE
Imprint
G12 5 114
Color
white
Shape
OVAL
Form
TABLET
Labeler
Granules Pharmaceuticals Inc.
Schedule
CII
NDC
70010-114 · 2026-06-18
Lannett 07
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
Lannett 0795
Color
white
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Golden State Medical Supply, Inc.
Schedule
CII
NDC
51407-562 · 2026-06-18
G15 115
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
G15 115
Color
white
Shape
ROUND
Form
TABLET
Labeler
Granules Pharmaceuticals Inc.
Schedule
CII
NDC
70010-115 · 2026-06-18
E 401
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
E 401
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
Sandoz Inc
Schedule
CII
NDC
0185-0853 · 2026-06-18
G20 116
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
G20 116
Color
white
Shape
OVAL
Form
TABLET
Labeler
Granules Pharmaceuticals Inc.
Schedule
CII
NDC
70010-116 · 2026-06-18
A2
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 6.3 mg/1
Imprint
A2
Color
orange
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Neos Therapeutics, LP
Schedule
CII
NDC
62542-010 · 2026-06-18
A3
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 9.4 mg/1
Imprint
A3
Color
orange
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Neos Therapeutics, LP
Schedule
CII
NDC
62542-015 · 2026-06-18
A4
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 12.5 mg/1
Imprint
A4
Color
orange
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Neos Therapeutics, LP
Schedule
CII
NDC
62542-020 · 2026-06-18
A5
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 15.7 mg/1
Imprint
A5
Color
orange
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Neos Therapeutics, LP
Schedule
CII
NDC
62542-025 · 2026-06-18
A6
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 18.8 mg/1
Imprint
A6
Color
orange
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Neos Therapeutics, LP
Schedule
CII
NDC
62542-030 · 2026-06-18
E 84
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
E 84
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
Sandoz Inc
Schedule
CII
NDC
0185-2098 · 2026-06-18
M Amphet S
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
M Amphet Salts 5 mg
Color
BLUE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Sandoz Inc
Schedule
CII
NDC
0781-2329 · 2026-06-18
E 404
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
E 404
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
Sandoz Inc
Schedule
CII
NDC
0185-2099 · 2026-06-18
5 E29
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
5 E29
Color
WHITE
Shape
ROUND
Form
TABLET
Labeler
Epic Pharma LLC
Schedule
CII
NDC
42806-029 · 2026-06-18
ADDERALL X
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
ADDERALL XR 20 mg
Color
ORANGE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Takeda Pharmaceuticals America, Inc.
Schedule
CII
NDC
54092-387 · 2026-06-18
7 5 d p
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DE
Imprint
7 5 d p
Color
blue
Shape
OVAL
Form
TABLET
Labeler
Teva Pharmaceuticals USA, Inc.
Schedule
CII
NDC
57844-117 · 2026-06-18
NP008 10
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTROAMPHETAMINE
Imprint
NP008 10
Color
white
Shape
ROUND
Form
TABLET
Labeler
Neolpharma, Inc.
Schedule
CII
NDC
55466-130 · 2026-06-18
ADDERALL X
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
ADDERALL XR 5 mg
Color
BLUE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Takeda Pharmaceuticals America, Inc.
Schedule
CII
NDC
54092-381 · 2026-06-18
1 0 dp
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
1 0 dp
Color
blue
Shape
ROUND
Form
TABLET
Labeler
Teva Pharmaceuticals USA, Inc.
Schedule
CII
NDC
57844-110 · 2026-06-18
ADDERALL X
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
ADDERALL XR 10 mg
Color
BLUE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Takeda Pharmaceuticals America, Inc.
Schedule
CII
NDC
54092-383 · 2026-06-18
12 5 d p
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DE
Imprint
12 5 d p
Color
orange
Shape
ROUND
Form
TABLET
Labeler
Teva Pharmaceuticals USA, Inc.
Schedule
CII
NDC
57844-112 · 2026-06-18
NP007 5
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXTROAMPHETAMIN
Imprint
NP007 5
Color
white
Shape
ROUND
Form
TABLET
Labeler
Neolpharma, Inc.
Schedule
CII
NDC
55466-129 · 2026-06-18
ADDERALL X
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
ADDERALL XR 15 mg
Color
WHITE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Takeda Pharmaceuticals America, Inc.
Schedule
CII
NDC
54092-385 · 2026-06-18
15 d p
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
15 d p
Color
orange
Shape
OVAL
Form
TABLET
Labeler
Teva Pharmaceuticals USA, Inc.
Schedule
CII
NDC
57844-115 · 2026-06-18
10 E30
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
10 E30
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
Epic Pharma LLC
Schedule
CII
NDC
42806-030 · 2026-06-18
ADDERALL X
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
ADDERALL XR 25 mg
Color
WHITE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Takeda Pharmaceuticals America, Inc.
Schedule
CII
NDC
54092-389 · 2026-06-18
2 0 dp
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
2 0 dp
Color
orange
Shape
ROUND
Form
TABLET
Labeler
Teva Pharmaceuticals USA, Inc.
Schedule
CII
NDC
57844-120 · 2026-06-18
NP009 15
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXTROAMPHETAMIN
Imprint
NP009 15
Color
orange
Shape
ROUND
Form
TABLET
Labeler
Neolpharma, Inc.
Schedule
CII
NDC
55466-131 · 2026-06-18
ADDERALL X
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
ADDERALL XR 30 mg
Color
ORANGE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Takeda Pharmaceuticals America, Inc.
Schedule
CII
NDC
54092-391 · 2026-06-18
A17
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 3.1 mg/1
Imprint
A17
Color
yellow
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Teva Pharmaceuticals, Inc.
Schedule
CII
NDC
0480-3315 · 2026-06-18
3 0 dp
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
3 0 dp
Color
orange
Shape
ROUND
Form
TABLET
Labeler
Teva Pharmaceuticals USA, Inc.
Schedule
CII
NDC
57844-130 · 2026-06-18
NP010 20
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPHETAMINE SACC
Imprint
NP010 20
Color
orange
Shape
ROUND
Form
TABLET
Labeler
Neolpharma, Inc.
Schedule
CII
NDC
55466-132 · 2026-06-18
M Amphet S
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
M Amphet Salts 15 mg
Color
WHITE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Sandoz Inc
Schedule
CII
NDC
0781-2343 · 2026-06-18
SHIRE 465
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DE
Imprint
SHIRE 465 12 5mg
Color
GREEN
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Takeda Pharmaceuticals America, Inc.
Schedule
CII
NDC
54092-468 · 2026-06-18
NP011 30
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTROAMPHETAMINE
Imprint
NP011 30
Color
white
Shape
ROUND
Form
TABLET
Labeler
Neolpharma, Inc.
Schedule
CII
NDC
55466-133 · 2026-06-18
RP 705
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
RP 705
Color
BROWN
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Rhodes Pharmaceuticals LLC
Schedule
CII
NDC
42858-055 · 2026-06-18
SHIRE 465
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 12.5 mg/1; AMPHETAMINE SULFATE 12.5 mg/1; DEXT
Imprint
SHIRE 465 50mg
Color
PURPLE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Takeda Pharmaceuticals America, Inc.
Schedule
CII
NDC
54092-477 · 2026-06-18
SHIRE 465
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
SHIRE 465 25mg
Color
WHITE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Takeda Pharmaceuticals America, Inc.
Schedule
CII
NDC
54092-471 · 2026-06-18
SHIRE 465
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 9.375 mg/1; AMPHETAMINE SULFATE 9.375 mg/1; DE
Imprint
SHIRE 465 37 5mg
Color
WHITE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Takeda Pharmaceuticals America, Inc.
Schedule
CII
NDC
54092-474 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE
Labeler
Amneal Pharmaceuticals of New York LLC
Schedule
CII
NDC
0115-1487 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-1368 · 2026-06-18
20mg ELI 5
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
20mg ELI 513
Color
pink
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Burel Pharmaceuticals, LLC
Schedule
CII
NDC
35573-467 · 2026-06-18
5mg ELI 51
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
5mg ELI 510
Color
green
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Burel Pharmaceuticals, LLC
Schedule
CII
NDC
35573-464 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-1369 · 2026-06-18
A118
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 6.3 mg/1
Imprint
A118
Color
yellow
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Teva Pharmaceuticals, Inc.
Schedule
CII
NDC
0480-3316 · 2026-06-18
M Amphet S
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
M Amphet Salts 20 mg
Color
ORANGE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Sandoz Inc
Schedule
CII
NDC
0781-2352 · 2026-06-18
10mg ELI 5
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
10mg ELI 511
Color
blue
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Burel Pharmaceuticals, LLC
Schedule
CII
NDC
35573-465 · 2026-06-18
15mg ELI 5
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
15mg ELI 512
Color
green
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Burel Pharmaceuticals, LLC
Schedule
CII
NDC
35573-466 · 2026-06-18
A2
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 6.3 mg/1
Imprint
A2
Color
orange
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Neos Therapeutics Brands, LLC
Schedule
CII
NDC
70165-010 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
71335-2070 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-1380 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-1377 · 2026-06-18
25mg ELI 5
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
25mg ELI 514
Color
pink
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Burel Pharmaceuticals, LLC
Schedule
CII
NDC
35573-468 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-1378 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE
Labeler
Amneal Pharmaceuticals of New York LLC
Schedule
CII
NDC
0115-1488 · 2026-06-18
30mg ELI 5
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
30mg ELI 515
Color
pink
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Burel Pharmaceuticals, LLC
Schedule
CII
NDC
35573-469 · 2026-06-18
A1
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 3.1 mg/1
Imprint
A1
Color
orange
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Neos Therapeutics Brands, LLC
Schedule
CII
NDC
70165-005 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-1379 · 2026-06-18
A5
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 15.7 mg/1
Imprint
A5
Color
orange
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Neos Therapeutics Brands, LLC
Schedule
CII
NDC
70165-025 · 2026-06-18
A119
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 9.4 mg/1
Imprint
A119
Color
yellow
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Teva Pharmaceuticals, Inc.
Schedule
CII
NDC
0480-3317 · 2026-06-18
A3
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 9.4 mg/1
Imprint
A3
Color
orange
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Neos Therapeutics Brands, LLC
Schedule
CII
NDC
70165-015 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-1381 · 2026-06-18
A4
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 12.5 mg/1
Imprint
A4
Color
orange
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Neos Therapeutics Brands, LLC
Schedule
CII
NDC
70165-020 · 2026-06-18
A6
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 18.8 mg/1
Imprint
A6
Color
orange
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Neos Therapeutics Brands, LLC
Schedule
CII
NDC
70165-030 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE
Labeler
Amneal Pharmaceuticals of New York LLC
Schedule
CII
NDC
0115-1489 · 2026-06-18
A285
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 12.5 mg/1
Imprint
A285
Color
yellow
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Teva Pharmaceuticals, Inc.
Schedule
CII
NDC
0480-3318 · 2026-06-18
RP 715
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
RP 715
Color
BLUE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Rhodes Pharmaceuticals LLC
Schedule
CII
NDC
42858-215 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE
Labeler
Amneal Pharmaceuticals of New York LLC
Schedule
CII
NDC
0115-1490 · 2026-06-18
RP 725
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
RP 725
Color
ORANGE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Rhodes Pharmaceuticals LLC
Schedule
CII
NDC
42858-325 · 2026-06-18
A121
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 15.7 mg/1
Imprint
A121
Color
yellow
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Teva Pharmaceuticals, Inc.
Schedule
CII
NDC
0480-3319 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE
Labeler
Amneal Pharmaceuticals of New York LLC
Schedule
CII
NDC
0115-1491 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
DR. REDDY'S LABORATORIES INC
Schedule
CII
NDC
43598-897 · 2026-06-18
MP 444
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DEXTROAMPHETAM
Imprint
MP 444
Color
yellow
Shape
ROUND
Form
TABLET
Labeler
Northstar Rx LLC
Schedule
CII
NDC
16714-805 · 2026-06-18
RP 710
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
RP 710
Color
BLUE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Rhodes Pharmaceuticals LLC
Schedule
CII
NDC
42858-610 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Alvogen Inc.
Schedule
CII
NDC
47781-178 · 2026-06-18
10
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
10
Color
blue
Shape
ROUND
Form
TABLET
Labeler
Amneal Pharmaceuticals NY LLC
Schedule
CII
NDC
69238-1564 · 2026-06-18
MP 441
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXTROAMPHETAMIN
Imprint
MP 441
Color
green
Shape
ROUND
Form
TABLET
Labeler
Northstar Rx LLC
Schedule
CII
NDC
16714-802 · 2026-06-18
MP 442
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DEXTROAMPHETAM
Imprint
MP 442
Color
green
Shape
OVAL
Form
TABLET
Labeler
Northstar Rx LLC
Schedule
CII
NDC
16714-803 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Alvogen Inc.
Schedule
CII
NDC
47781-174 · 2026-06-18
MP 443
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTROAMPHETAMINE
Imprint
MP 443
Color
green
Shape
ROUND
Form
TABLET
Labeler
Northstar Rx LLC
Schedule
CII
NDC
16714-804 · 2026-06-18
C 2 1 8
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
C 2 1 8
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
DR. REDDY'S LABORATORIES INC
Schedule
CII
NDC
43598-898 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Alvogen Inc.
Schedule
CII
NDC
47781-176 · 2026-06-18
5
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
5
Color
white
Shape
ROUND
Form
TABLET
Labeler
Amneal Pharmaceuticals NY LLC
Schedule
CII
NDC
69238-1563 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Alvogen Inc.
Schedule
CII
NDC
47781-180 · 2026-06-18
MP 445
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXTROAMPHETAMIN
Imprint
MP 445
Color
yellow
Shape
OVAL
Form
TABLET
Labeler
Northstar Rx LLC
Schedule
CII
NDC
16714-806 · 2026-06-18
80 A
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
80 A
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
Alvogen Inc.
Schedule
CII
NDC
47781-179 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
63629-2378 · 2026-06-18
A122
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 18.8 mg/1
Imprint
A122
Color
yellow
Shape
ROUND
Form
TABLET, ORALLY DISINTEGRATING
Labeler
Teva Pharmaceuticals, Inc.
Schedule
CII
NDC
0480-3320 · 2026-06-18
b 971 5
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
b 971 5
Color
blue
Shape
OVAL
Form
TABLET
Labeler
Teva Pharmaceuticals USA, Inc.
Schedule
CII
NDC
0555-0971 · 2026-06-18
MP 446
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPHETAMINE SACC
Imprint
MP 446
Color
yellow
Shape
ROUND
Form
TABLET
Labeler
Northstar Rx LLC
Schedule
CII
NDC
16714-807 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
63629-2380 · 2026-06-18
MP 447
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTROAMPHETAMINE
Imprint
MP 447
Color
yellow
Shape
ROUND
Form
TABLET
Labeler
Northstar Rx LLC
Schedule
CII
NDC
16714-808 · 2026-06-18
RP 21
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
RP 21
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
Rhodes Pharmaceuticals LLC
Schedule
CII
NDC
42858-721 · 2026-06-18
NP010 20
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE DL-ASPARTATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPHETAMINE S
Imprint
NP010 20
Color
orange
Shape
ROUND
Form
TABLET
Labeler
GLENMARK PHARMACEUTICALS INC., USA
Schedule
CII
NDC
68462-652 · 2026-06-18
5 S
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
5 S
Color
WHITE
Shape
ROUND
Form
TABLET
Labeler
Solco Healthcare US, LLC
Schedule
CII
NDC
43547-457 · 2026-06-18
NP007 5
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE DL-ASPARTATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXTROAMPHETA
Imprint
NP007 5
Color
white
Shape
ROUND
Form
TABLET
Labeler
GLENMARK PHARMACEUTICALS INC., USA
Schedule
CII
NDC
68462-647 · 2026-06-18
1 0 S
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
1 0 S
Color
WHITE
Shape
ROUND
Form
TABLET
Labeler
Solco Healthcare US, LLC
Schedule
CII
NDC
43547-458 · 2026-06-18
NP008 10
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE DL-ASPARTATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTROAMPHETAMI
Imprint
NP008 10
Color
white
Shape
ROUND
Form
TABLET
Labeler
GLENMARK PHARMACEUTICALS INC., USA
Schedule
CII
NDC
68462-649 · 2026-06-18
RP 720
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
RP 720
Color
ORANGE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Rhodes Pharmaceuticals LLC
Schedule
CII
NDC
42858-720 · 2026-06-18
NP009 15
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE DL-ASPARTATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXTROAMPHETA
Imprint
NP009 15
Color
orange
Shape
ROUND
Form
TABLET
Labeler
GLENMARK PHARMACEUTICALS INC., USA
Schedule
CII
NDC
68462-651 · 2026-06-18
A24
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
A24
Color
WHITE
Shape
ROUND
Form
TABLET
Labeler
Lannett Company, Inc.
Schedule
CII
NDC
0527-2524 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
63629-1973 · 2026-06-18
b 972 1 0
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
b 972 1 0
Color
blue
Shape
OVAL
Form
TABLET
Labeler
Teva Pharmaceuticals USA, Inc.
Schedule
CII
NDC
0555-0972 · 2026-06-18
RP 22
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DE
Imprint
RP 22
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
Rhodes Pharmaceuticals LLC
Schedule
CII
NDC
42858-722 · 2026-06-18
NP011 30
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE DL-ASPARTATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTROAMPHETAMI
Imprint
NP011 30
Color
white
Shape
ROUND
Form
TABLET
Labeler
GLENMARK PHARMACEUTICALS INC., USA
Schedule
CII
NDC
68462-653 · 2026-06-18
RP 23
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
RP 23
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
Rhodes Pharmaceuticals LLC
Schedule
CII
NDC
42858-723 · 2026-06-18
RP 24
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DE
Imprint
RP 24
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
Rhodes Pharmaceuticals LLC
Schedule
CII
NDC
42858-724 · 2026-06-18
RP 27
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
RP 27
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
Rhodes Pharmaceuticals LLC
Schedule
CII
NDC
42858-727 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
63629-1976 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
63629-1974 · 2026-06-18
M Amphet S
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
M Amphet Salts 25 mg
Color
WHITE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Sandoz Inc
Schedule
CII
NDC
0781-2368 · 2026-06-18
RP 25
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
RP 25
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
Rhodes Pharmaceuticals LLC
Schedule
CII
NDC
42858-725 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
63629-1975 · 2026-06-18
RP 26
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
RP 26
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
Rhodes Pharmaceuticals LLC
Schedule
CII
NDC
42858-726 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
63629-1977 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
63629-1978 · 2026-06-18
A25
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
A25
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
Lannett Company, Inc.
Schedule
CII
NDC
0527-2525 · 2026-06-18
b 973 2 0
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
b 973 2 0
Color
orange
Shape
OVAL
Form
TABLET
Labeler
Teva Pharmaceuticals USA, Inc.
Schedule
CII
NDC
0555-0973 · 2026-06-18
MP 441
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXTROAMPHETAMIN
Imprint
MP 441
Color
green
Shape
ROUND
Form
TABLET
Labeler
Sun Pharmaceutical Industries, Inc.
Schedule
CII
NDC
57664-641 · 2026-06-18
M Amphet S
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
M Amphet Salts 30 mg
Color
ORANGE
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Sandoz Inc
Schedule
CII
NDC
0781-2371 · 2026-06-18
RP 730
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
RP 730
Color
BROWN
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Rhodes Pharmaceuticals LLC
Schedule
CII
NDC
42858-930 · 2026-06-18
E343
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
E343
Color
PINK
Shape
OVAL
Form
TABLET
Labeler
Epic Pharma, LLC
Schedule
CII
NDC
42806-343 · 2026-06-18
MP 444
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DEXTROAMPHETAM
Imprint
MP 444
Color
yellow
Shape
ROUND
Form
TABLET
Labeler
Sun Pharmaceutical Industries, Inc.
Schedule
CII
NDC
57664-644 · 2026-06-18
E above 33
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
E above 339
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
Epic Pharma, LLC
Schedule
CII
NDC
42806-339 · 2026-06-18
MP 442
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DEXTROAMPHETAM
Imprint
MP 442
Color
green
Shape
OVAL
Form
TABLET
Labeler
Sun Pharmaceutical Industries, Inc.
Schedule
CII
NDC
57664-642 · 2026-06-18
E above 34
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
E above 341
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
Epic Pharma, LLC
Schedule
CII
NDC
42806-341 · 2026-06-18
0 5 LCI
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
0 5 LCI
Color
blue
Shape
ROUND
Form
TABLET
Labeler
Lannett Company, Inc.
Schedule
CII
NDC
0527-0760 · 2026-06-18
MP 443
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTROAMPHETAMINE
Imprint
MP 443
Color
green
Shape
ROUND
Form
TABLET
Labeler
Sun Pharmaceutical Industries, Inc.
Schedule
CII
NDC
57664-643 · 2026-06-18
E above 34
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
E above 344
Color
PINK
Shape
ROUND
Form
TABLET
Labeler
Epic Pharma, LLC
Schedule
CII
NDC
42806-344 · 2026-06-18
MP 445
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXTROAMPHETAMIN
Imprint
MP 445
Color
yellow
Shape
OVAL
Form
TABLET
Labeler
Sun Pharmaceutical Industries, Inc.
Schedule
CII
NDC
57664-645 · 2026-06-18
E above 34
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
E above 345
Color
PINK
Shape
ROUND
Form
TABLET
Labeler
Epic Pharma, LLC
Schedule
CII
NDC
42806-345 · 2026-06-18
7 5 M
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DE
Imprint
7 5 M
Color
white
Shape
SQUARE
Form
TABLET
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-8884 · 2026-06-18
b 974 3 0
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
b 974 3 0
Color
orange
Shape
OVAL
Form
TABLET
Labeler
Teva Pharmaceuticals USA, Inc.
Schedule
CII
NDC
0555-0974 · 2026-06-18
MP 446
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPHETAMINE SACC
Imprint
MP 446
Color
yellow
Shape
ROUND
Form
TABLET
Labeler
Sun Pharmaceutical Industries, Inc.
Schedule
CII
NDC
57664-646 · 2026-06-18
25 mg M
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
25 mg M
Color
white
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-0803 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-2251 · 2026-06-18
MP 447
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTROAMPHETAMINE
Imprint
MP 447
Color
yellow
Shape
ROUND
Form
TABLET
Labeler
Sun Pharmaceutical Industries, Inc.
Schedule
CII
NDC
57664-647 · 2026-06-18
u 26
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DE
Imprint
u 26
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
Aurolife Pharma, LLC
Schedule
CII
NDC
13107-069 · 2026-06-18
7 5 LCI
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DE
Imprint
7 5 LCI
Color
blue
Shape
ROUND
Form
TABLET
Labeler
Lannett Company, Inc.
Schedule
CII
NDC
0527-0761 · 2026-06-18
u 25
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
u 25
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
Aurolife Pharma, LLC
Schedule
CII
NDC
13107-068 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE
Labeler
Amneal Pharmaceuticals of New York LLC
Schedule
CII
NDC
0115-1486 · 2026-06-18
5 dp
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
5 dp
Color
white
Shape
ROUND
Form
TABLET
Labeler
Teva Pharmaceuticals USA, Inc.
Schedule
CII
NDC
57844-105 · 2026-06-18
u 30
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
u 30
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
Aurolife Pharma, LLC
Schedule
CII
NDC
13107-073 · 2026-06-18
u 27
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
u 27
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
Aurolife Pharma, LLC
Schedule
CII
NDC
13107-070 · 2026-06-18
15 M
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
15 M
Color
white
Shape
OCTAGON (8 sided)
Form
TABLET
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-8885 · 2026-06-18
u 28
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DE
Imprint
u 28
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
Aurolife Pharma, LLC
Schedule
CII
NDC
13107-071 · 2026-06-18
50 mg M
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 12.5 mg/1; AMPHETAMINE SULFATE 12.5 mg/1; DEXT
Imprint
50 mg M
Color
blue
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-0804 · 2026-06-18
u 29
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
u 29
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
Aurolife Pharma, LLC
Schedule
CII
NDC
13107-072 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
71335-1081 · 2026-06-18
15
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 15 mg/1
Imprint
15
Color
white
Shape
TRIANGLE
Form
TABLET, EXTENDED RELEASE
Labeler
NextWave Pharmaceuticals, Inc
Schedule
CII
NDC
24478-109 · 2026-06-18
u 31
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
u 31
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
Aurolife Pharma, LLC
Schedule
CII
NDC
13107-074 · 2026-06-18
5
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 5 mg/1
Imprint
5
Color
white
Shape
CAPSULE
Form
TABLET, EXTENDED RELEASE
Labeler
NextWave Pharmaceuticals, Inc
Schedule
CII
NDC
24478-106 · 2026-06-18
10
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 10 mg/1
Imprint
10
Color
white
Shape
DIAMOND
Form
TABLET, EXTENDED RELEASE
Labeler
NextWave Pharmaceuticals, Inc
Schedule
CII
NDC
24478-108 · 2026-06-18
T 372
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
T 372
Color
blue
Shape
ROUND
Form
TABLET
Labeler
Camber Pharmaceuticals, Inc.
Schedule
CII
NDC
31722-157 · 2026-06-18
5 M
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
5 M
Color
white
Shape
SQUARE
Form
TABLET
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-8891 · 2026-06-18
20
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE 20 mg/1
Imprint
20
Color
white
Shape
OVAL
Form
TABLET, EXTENDED RELEASE
Labeler
NextWave Pharmaceuticals, Inc
Schedule
CII
NDC
24478-110 · 2026-06-18
10 LCI
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
10 LCI
Color
blue
Shape
ROUND
Form
TABLET
Labeler
Lannett Company, Inc.
Schedule
CII
NDC
0527-0762 · 2026-06-18
T370
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
T370
Color
white
Shape
ROUND
Form
TABLET
Labeler
Camber Pharmaceuticals, Inc.
Schedule
CII
NDC
31722-155 · 2026-06-18
T371
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DE
Imprint
T371
Color
blue
Shape
OVAL
Form
TABLET
Labeler
Camber Pharmaceuticals, Inc.
Schedule
CII
NDC
31722-156 · 2026-06-18
u 25
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
u 25
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
NorthStar RxLLC
Schedule
CII
NDC
16714-948 · 2026-06-18
T 373
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DE
Imprint
T 373
Color
orange
Shape
ROUND
Form
TABLET
Labeler
Camber Pharmaceuticals, Inc.
Schedule
CII
NDC
31722-158 · 2026-06-18
12 5 mg M
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DE
Imprint
12 5 mg M
Color
yellow
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-0805 · 2026-06-18
T374
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
T374
Color
orange
Shape
OVAL
Form
TABLET
Labeler
Camber Pharmaceuticals, Inc.
Schedule
CII
NDC
31722-159 · 2026-06-18
u 29
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
u 29
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
NorthStar RxLLC
Schedule
CII
NDC
16714-952 · 2026-06-18
12 5 LCI
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DE
Imprint
12 5 LCI
Color
orange
Shape
ROUND
Form
TABLET
Labeler
Lannett Company, Inc.
Schedule
CII
NDC
0527-0763 · 2026-06-18
952 37 5mg
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 9.375 mg/1; AMPHETAMINE SULFATE 9.375 mg/1; DE
Imprint
952 37 5mg
Color
white
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Sun Pharmaceutical Industries, Inc.
Schedule
CII
NDC
57664-952 · 2026-06-18
950 12 5mg
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DE
Imprint
950 12 5mg
Color
green
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Sun Pharmaceutical Industries, Inc.
Schedule
CII
NDC
57664-950 · 2026-06-18
u 26
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DE
Imprint
u 26
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
NorthStar RxLLC
Schedule
CII
NDC
16714-949 · 2026-06-18
T 375
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
T 375
Color
orange
Shape
ROUND
Form
TABLET
Labeler
Camber Pharmaceuticals, Inc.
Schedule
CII
NDC
31722-163 · 2026-06-18
u 27
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
u 27
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
NorthStar RxLLC
Schedule
CII
NDC
16714-950 · 2026-06-18
T 376
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
T 376
Color
orange
Shape
ROUND
Form
TABLET
Labeler
Camber Pharmaceuticals, Inc.
Schedule
CII
NDC
31722-164 · 2026-06-18
951 25mg
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
951 25mg
Color
white
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Sun Pharmaceutical Industries, Inc.
Schedule
CII
NDC
57664-951 · 2026-06-18
u 30
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
u 30
Color
ORANGE
Shape
ROUND
Form
TABLET
Labeler
NorthStar RxLLC
Schedule
CII
NDC
16714-953 · 2026-06-18
953 50mg
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 12.5 mg/1; AMPHETAMINE SULFATE 12.5 mg/1; DEXT
Imprint
953 50mg
Color
white
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Sun Pharmaceutical Industries, Inc.
Schedule
CII
NDC
57664-953 · 2026-06-18
10 M
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
10 M
Color
white
Shape
SQUARE
Form
TABLET
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-8892 · 2026-06-18
37 5 mg M
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 9.375 mg/1; AMPHETAMINE SULFATE 9.375 mg/1; DE
Imprint
37 5 mg M
Color
blue
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-0807 · 2026-06-18
15 LCI
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
15 LCI
Color
orange
Shape
ROUND
Form
TABLET
Labeler
Lannett Company, Inc.
Schedule
CII
NDC
0527-0764 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
63629-2078 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
63629-2079 · 2026-06-18
R3059
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
R3059
Color
blue
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Actavis Pharma, Inc.
Schedule
CII
NDC
0228-3059 · 2026-06-18
U150 5
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
U150 5
Color
WHITE
Shape
ROUND
Form
TABLET
Labeler
Aurolife Pharma, LLC
Schedule
CII
NDC
13107-259 · 2026-06-18
U151 10
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
U151 10
Color
BLUE
Shape
ROUND
Form
TABLET
Labeler
Aurolife Pharma, LLC
Schedule
CII
NDC
13107-260 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
63629-2498 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
63629-2499 · 2026-06-18
20 M
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
20 M
Color
white
Shape
OCTAGON (8 sided)
Form
TABLET
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-8893 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DE
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Teva Pharmaceuticals, Inc.
Schedule
CII
NDC
0480-3683 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-1088 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-1087 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Prasco Laboratories
Schedule
CII
NDC
66993-594 · 2026-06-18
R3060
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
R3060
Color
blue
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Actavis Pharma, Inc.
Schedule
CII
NDC
0228-3060 · 2026-06-18
20 LCI
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
20 LCI
Color
orange
Shape
ROUND
Form
TABLET
Labeler
Lannett Company, Inc.
Schedule
CII
NDC
0527-0765 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Camber Pharmaceuticals, Inc.
Schedule
CII
NDC
31722-185 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Oryza Pharmaceuticals Inc.
Schedule
CII
NDC
72516-011 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Prasco Laboratories
Schedule
CII
NDC
66993-595 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Prasco Laboratories
Schedule
CII
NDC
66993-596 · 2026-06-18
30 M
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
30 M
Color
white
Shape
OCTAGON (8 sided)
Form
TABLET
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-8894 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Teva Pharmaceuticals, Inc.
Schedule
CII
NDC
0480-3684 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Prasco Laboratories
Schedule
CII
NDC
66993-597 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Camber Pharmaceuticals, Inc.
Schedule
CII
NDC
31722-189 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DE
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Oryza Pharmaceuticals Inc.
Schedule
CII
NDC
72516-015 · 2026-06-18
R3061
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
R3061
Color
orange
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Actavis Pharma, Inc.
Schedule
CII
NDC
0228-3061 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Camber Pharmaceuticals, Inc.
Schedule
CII
NDC
31722-186 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Prasco Laboratories
Schedule
CII
NDC
66993-598 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Oryza Pharmaceuticals Inc.
Schedule
CII
NDC
72516-012 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Camber Pharmaceuticals, Inc.
Schedule
CII
NDC
31722-187 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Prasco Laboratories
Schedule
CII
NDC
66993-599 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Oryza Pharmaceuticals Inc.
Schedule
CII
NDC
72516-013 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Camber Pharmaceuticals, Inc.
Schedule
CII
NDC
31722-188 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Oryza Pharmaceuticals Inc.
Schedule
CII
NDC
72516-014 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Oryza Pharmaceuticals Inc.
Schedule
CII
NDC
72516-016 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Elite Laboratories, Inc.
Schedule
CII
NDC
64850-500 · 2026-06-18
30 LCI
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
30 LCI
Color
orange
Shape
ROUND
Form
TABLET
Labeler
Lannett Company, Inc.
Schedule
CII
NDC
0527-0766 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DE
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Elite Laboratories, Inc.
Schedule
CII
NDC
64850-501 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Elite Laboratories, Inc.
Schedule
CII
NDC
64850-505 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Elite Laboratories, Inc.
Schedule
CII
NDC
64850-502 · 2026-06-18
5 mg M 895
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
5 mg M 8951
Color
orange
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-8951 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 9.375 mg/1; AMPHETAMINE SULFATE 9.375 mg/1; DE
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Teva Pharmaceuticals, Inc.
Schedule
CII
NDC
0480-3685 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Camber Pharmaceuticals, Inc.
Schedule
CII
NDC
31722-195 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DE
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Elite Laboratories, Inc.
Schedule
CII
NDC
64850-503 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Elite Laboratories, Inc.
Schedule
CII
NDC
64850-504 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Elite Laboratories, Inc.
Schedule
CII
NDC
64850-512 · 2026-06-18
R3062
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
R3062
Color
blue
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Actavis Pharma, Inc.
Schedule
CII
NDC
0228-3062 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Wilshire Pharmaceuticals, Inc.
Schedule
CII
NDC
52536-057 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Elite Laboratories, Inc.
Schedule
CII
NDC
64850-506 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Elite Laboratories, Inc.
Schedule
CII
NDC
64850-510 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Wilshire Pharmaceuticals, Inc.
Schedule
CII
NDC
52536-059 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Elite Laboratories, Inc.
Schedule
CII
NDC
64850-511 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Elite Laboratories, Inc.
Schedule
CII
NDC
64850-515 · 2026-06-18
10 mg M 89
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
10 mg M 8952
Color
blue
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-8952 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 12.5 mg/1; AMPHETAMINE SULFATE 12.5 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Teva Pharmaceuticals, Inc.
Schedule
CII
NDC
0480-3686 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Elite Laboratories, Inc.
Schedule
CII
NDC
64850-513 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
71335-2990 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Lannett Company, Inc.
Schedule
CII
NDC
0527-0790 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Elite Laboratories, Inc.
Schedule
CII
NDC
64850-514 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
63629-1114 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
63629-1115 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Lannett Company, Inc.
Schedule
CII
NDC
0527-0791 · 2026-06-18
R3063
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
R3063
Color
orange
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Actavis Pharma, Inc.
Schedule
CII
NDC
0228-3063 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-1219 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-1613 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-2050 · 2026-06-18
b 775 7 1
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DE
Imprint
b 775 7 1 2
Color
blue
Shape
ROUND
Form
TABLET
Labeler
Teva Pharmaceuticals USA, Inc.
Schedule
CII
NDC
0555-0775 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-2048 · 2026-06-18
15 mg M 89
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
15 mg M 8953
Color
white
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-8953 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-1612 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DE
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-2049 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Granules Pharmaceuticals Inc.
Schedule
CII
NDC
70010-031 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-2053 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg/1; AMPHETAMINE SULFATE 1.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Granules Pharmaceuticals Inc.
Schedule
CII
NDC
70010-029 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DE
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-2051 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg/1; AMPHETAMINE SULFATE 2.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Granules Pharmaceuticals Inc.
Schedule
CII
NDC
70010-030 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-2052 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Granules Pharmaceuticals Inc.
Schedule
CII
NDC
70010-040 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Granules Pharmaceuticals Inc.
Schedule
CII
NDC
70010-032 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-2054 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Granules Pharmaceuticals Inc.
Schedule
CII
NDC
70010-033 · 2026-06-18
R3064
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
R3064
Color
white
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
Actavis Pharma, Inc.
Schedule
CII
NDC
0228-3064 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg/1; AMPHETAMINE SULFATE 7.5 mg/1; DEXTRO
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Granules Pharmaceuticals Inc.
Schedule
CII
NDC
70010-034 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Lannett Company, Inc.
Schedule
CII
NDC
0527-0792 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Granules Pharmaceuticals Inc.
Schedule
CII
NDC
70010-041 · 2026-06-18
20 mg M 89
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
20 mg M 8954
Color
orange
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-8954 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-1220 · 2026-06-18
b 776 12 1
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DE
Imprint
b 776 12 1 2
Color
orange
Shape
OVAL
Form
TABLET
Labeler
Teva Pharmaceuticals USA, Inc.
Schedule
CII
NDC
0555-0776 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 5 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Azurity Pharmaceuticals, Inc.
Schedule
CII
NDC
24338-022 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 1.875 mg/1; AMPHETAMINE SULFATE 1.875 mg/1; DE
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-1235 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.125 mg/1; AMPHETAMINE SULFATE 3.125 mg/1; DE
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Bryant Ranch Prepack
Schedule
CII
NDC
72162-1236 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE SULFATE 10 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Azurity Pharmaceuticals, Inc.
Schedule
CII
NDC
24338-026 · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg/1; AMPHETAMINE SULFATE 5 mg/1; DEXTROAMPH
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE, EXTENDED RELEASE
Labeler
Lannett Company, Inc.
Schedule
CII
NDC
0527-0793 · 2026-06-18
25 mg M 89
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 6.25 mg/1; AMPHETAMINE SULFATE 6.25 mg/1; DEXT
Imprint
25 mg M 8955
Color
white
Shape
CAPSULE
Form
CAPSULE, EXTENDED RELEASE
Labeler
SpecGx LLC
Schedule
CII
NDC
0406-8955 · 2026-06-18
b 777 1 5
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1; AMPHETAMINE SULFATE 3.75 mg/1; DEXT
Imprint
b 777 1 5
Color
orange
Shape
ROUND
Form
TABLET
Labeler
Teva Pharmaceuticals USA, Inc.
Schedule
CII
NDC
0555-0777 · 2026-06-18

Dosage

Pending medical reviewer

Sources

← Back to the drug index